Health Care: Drugs

Meridian Bioscience Inc (VIVO: NASDAQ)

$19.62 -0.09 | -0.46%
08/01/14 - 12:20 PM ET
Company Income Statement
Sep 2013 Sep 2012 Sep 2011 Sep 2010
Sales 188.69M 173.54M 159.72M 143.00M
Cost of Sales 60.49M 57.07M 54.55M 49.84M
Gross Operating Profit 128.20M 116.48M 105.17M 93.16M
Selling, General, and Administrative Expenses 52.94M 50.31M 49.44M 37.53M
Research & Development 10.79M 10.28M 9.82M 8.57M
Operating Income before D & A (EBITDA) 64.47M 55.89M 45.91M 47.06M
Depreciation & Amortization 7.15M 6.60M 5.87M 4.68M
Interest Income 44.00K 42.00K 115.00K 124.00K
Other Income - Net 4.00K 378.00K 352.00K -1.10M
Special Income / Charges 0.00 0.00 0.00 1.24M
Total Income Before Interest Expenses (EBIT) 57.36M 49.72M 40.50M 41.40M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income 57.36M 49.72M 40.50M 41.40M
Income Taxes 19.33M 16.34M 13.67M 14.75M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 38.03M 33.37M 26.83M 26.65M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 38.03M 33.37M 26.83M 26.65M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 38.03M 33.37M 26.83M 26.65M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
38.03M 33.37M 26.83M 26.65M
Preferred Dividends
Net Income Available To Common 38.03M 33.37M 26.83M 26.65M
Basic EPS from Continuing Ops. 0.92 0.81 0.66 0.66
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.92 0.81 0.66 0.66
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.92 0.81 0.66 0.66
Basic Normalized Net Income/Share 0.92 0.81 0.66 0.66
EPS fr Continuing Ops. 0.91 0.80 0.65 0.65
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.91 0.80 0.65 0.65
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.91 0.80 0.65 0.65
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.91 0.80 0.65 0.65
Dividends Paid per Share 0.76 0.76 0.76 0.74

Portfolios with VIVO

Latest VIVO Headlines from TheStreet

More Financial News for VIVO

Press Releases for VIVO

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter